Clarithromycin NDC 62332-344

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-344Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0344Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62332-344-30	62332034430	30 TABLET, FILM COATED in 1 BOTTLE (62332-344-30)Marketed from Feb 1, 2022
62332-344-60	62332034460	60 TABLET, FILM COATED in 1 BOTTLE (62332-344-60)Marketed from Feb 1, 2022
62332-344-91	62332034491	1000 TABLET, FILM COATED in 1 BOTTLE (62332-344-91)Marketed from Feb 1, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clarithromycin
Generic name (nonproprietary): clarithromycin
Active ingredients: Clarithromycin — 250 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Alembic Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210459
Marketing start: Feb 1, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Cytochrome P450 3A Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)Macrolides (Chemical structure)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 62332-344_ea098e34-02fb-4604-9b93-f8543b8fef4bSPL ID ea098e34-02fb-4604-9b93-f8543b8fef4bSPL set ID cde51c9f-f7b8-413f-8b8e-e56370cd5754RxCUI 197516, 197517UNII H1250JIK0A
Pharmacologic class: Macrolide Antimicrobial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332034430 followed by a unit qualifier and the quantity

Package 62332-0344-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 26, 2023.

Indications (excerpt from the label)

Clarithromycin tablets are a macrolide antimicrobial indicated for mild to moderate infections caused by designated, susceptible bacteria in the following: • Acute Bacterial Exacerbation of Chronic Bronchitis in Adults (1.1) • Acute Maxillary Sinusitis (1.2) • Community-Acquired Pneumonia (1.3) • Pharyngitis/Tonsillitis (1.4) • Uncomplicated Skin and Skin Structure Infections (1.5) • Acute Otitis Media in Pediatric Patients (1.6) • Treatment and Prophylaxis of Disseminated Mycobacterial Infections (1.7) • Helicobacter pylori Infection and Duodenal Ulcer Disease in Adults (1.8) Limitations of Use To reduce the development of drug-resistant bacteria and maintain the effectiveness of clarithrom…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210459

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210459
Product	Strength	Form · route	Labeler	Product NDC
Clarithromycin	Clarithromycin 500 mg/1	Tablet, Film coatedOral	Sportpharm LLC	85766-198
Clarithromycin	Clarithromycin 250 mg/1	Tablet, Film coatedOral	Sportpharm LLC	85766-197
Clarithromycin	Clarithromycin 250 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-344
Clarithromycin	Clarithromycin 500 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-345
Clarithromycin	Clarithromycin 500 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-345